BUSINESS REPORTER
SUHAR, NOV 3
SOHAR Port and Freezone has signed a land lease agreement with the Investment Group for Pharmaceutical Industries (a Free Zone Company) to establish a state-of-the-art pharmaceutical and medical supplies manufacturing plant on a 40,000-square-metre plot. The project, valued at approximately RO 7.7 million ($20 million), marks a new milestone in Oman’s growing industrial and healthcare landscape.
The facility, a joint venture between Omani investors and Algeria’s IMGSA Group, reflects SOHAR’s commitment to building a sustainable, investment-friendly environment that enhances trade and innovation. Operations are scheduled to begin in 2027, with the plant designed to meet the highest international manufacturing standards.
The factory will feature sterile production lines, advanced quality control laboratories, R&D units, and a dedicated training centre to nurture national expertise in pharmaceutical production and quality management. It will produce a broad range of medical products, including antibiotics, oncology treatments, medical gloves, sterile gauze, and other healthcare consumables.
Dr Tawfiq Houam, Chairman and CEO of IMGSA Group and co-founder of the investment consortium, said SOHAR was chosen for its “strategic location, advanced infrastructure, and integrated industrial ecosystem”. He added that the project aims to foster research, innovation, and talent development while advancing Oman’s self-sufficiency in healthcare and positioning the country as a regional pharmaceutical hub.
Eng Raed bin Mohammed al Rubaie, CEO of SOHAR Free Zone and Deputy CEO of Sohar Port, described the project as “a strategic addition to the Free Zone’s portfolio of advanced industries”. He emphasised that it will strengthen pharmaceutical supply chains locally and regionally, align with Oman Vision 2040 objectives and expand the base of sustainable industrial production. — ONA
Oman Observer is now on the WhatsApp channel. Click here
